News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Business
ProStrakan Group Unveils Amgen Collaboration Deal, Placing To Boost Cash Pile
July 13, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
ProStrakan Group PLC this morning unveiled a potentially lucrative collaboration deal with US biotechnology group Amgen Inc, alongside plans to raise 11.3 mln stg in a share placing to shore up its cash pile.
Twitter
LinkedIn
Facebook
Email
Print
Alliances
Europe
Amgen
MORE ON THIS TOPIC
Earnings
Merck Vaccine Sales Drop as US Declines Strike Another Pharma
October 30, 2025
·
1 min read
·
Dan Samorodnitsky
Layoff Tracker
Sensei Plans to Cut Workforce While Considering Strategic Alternatives
October 30, 2025
·
76 min read
·
BioSpace Editorial Staff
Earnings
BMS Battles ‘Deeply Ingrained’ Prescribing Habits in Schizophrenia as Cobenfy Misses Q3 Estimates
October 30, 2025
·
3 min read
·
Heather McKenzie
Earnings
Zepbound Topples Sales King Keytruda as Lilly Reports 54% YoY Revenue Rise for Q3
October 30, 2025
·
1 min read
·
Annalee Armstrong
